Hindustan Unilever Ltd.’s quarterly profit rose despite disruptions from the Covid-19 outbreak as the company benefited from higher sales of food items and the acquisition of GlaxoSmithKline Consumer Healthcare Ltd.
Net profit of India’s largest consumer goods maker rose 7.2% year-on-year to Rs 1,881 crore in the quarter ended June, according to an exchange filing.
That compares well with the Rs 1,722 crore of consensus estimates from Analysts by Bloomberg.
HUL, on April 1, announced that it has completed the takeover of GlaxoSmithKline Consumer Healthcare, bringing India’s largest selling malted milk drink Horlicks into its portfolio. Besides Horlicks, it gets Boost, Maltova and Viva brands.
This helped HUL tide over the impact of the pandemic. Without this acquisition volumes contracted 8% on a quarter on quarter basis.
for HUL Quarterly Results Presentation Read Here
for previous blogs on HUL Read Here
Net profit of India’s largest consumer goods maker rose 7.2% year-on-year to Rs 1,881 crore in the quarter ended June, according to an exchange filing.
That compares well with the Rs 1,722 crore of consensus estimates from Analysts by Bloomberg.
- Revenue rose 4.4% over last year to Rs 10,560 crore—higher than the estimated 9,880 crore.
- Operating profit fell 0.1% to Rs 2,644 crore.
- Margin narrowed to 25% from 26.2% earlier.
HUL, on April 1, announced that it has completed the takeover of GlaxoSmithKline Consumer Healthcare, bringing India’s largest selling malted milk drink Horlicks into its portfolio. Besides Horlicks, it gets Boost, Maltova and Viva brands.
This helped HUL tide over the impact of the pandemic. Without this acquisition volumes contracted 8% on a quarter on quarter basis.
HUL stock price - Past 1 year
HUL Stock Price - Past 5 years
for HUL Quarterly Results Presentation Read Here
for previous blogs on HUL Read Here
(Disclaimer : For information purposes only. Equity investing is a with risk investing including risk on principal invested. Please take an informed decision)
